Are common mutations of cystathionine β-synthase involved in the aetiology of neural tube defects?

Clinical Genetics

Volumn 51, Issue 1, 1997, Pages 39-42

  Ramsbottom, D ^a   Scott, J M ^a   Molloy, A ^a   Weir, D G ^a   Kirke, P N ^b   Mills, J L ^c   Gallagher, P M ^a   Whitehead, Alexander S ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b HEALTH RESEARCH BOARD   (Ireland)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

5,10 methylenetetrahydrofolate reductase; Cystathionine synthase; Genotyping; Hyperhomocysteinemia; Neural tube defects

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; IRELAND; MAJOR CLINICAL STUDY; MATERNAL PLASMA; NEURAL TUBE DEFECT; NEWBORN; NUTRITIONAL STATUS; POPULATION GENETICS; PRIORITY JOURNAL;

EID: 0031044302     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1997.tb02412.x     Document Type: Article

References (21)

1. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995: 10: 111-113.
2. Gallagher PM, Meleady R, Shields DC, Tan KS, McMaster D, Rozen R, Evans A,G Graham IM, Whitehead AS. Homocysteine and risk of coronary heart disease: evidence for a common gene mutation. Circulation 1996: 94: 2154-2158.
3. Gallagher PM, Ward P, Tan KS, Naughten E, Kraus JP, Sellar GC, McConnell DJ, Graham IM, Whitehead AS. High frequency (71%) of cystathionine β-synthase mutation G307S in Irish homocystinuria patients. Human Mutation 1995: 6: 177-180.
4. Goyette P, Frosst P, Rosenblatt DS, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlation in severe methylenetetra- hydrofolate reductase deficiency. Am J Hum Genet 1995: 56: 1052-1059.
5. Harmon DL, Woodside JV, Yarnell JWG, McMaster D, Young IS, McCrum EE, Gey KF, Whitehead AS, Evans A. The common "thermolabile" variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Q J Med 1996: 89: 571-577.
6. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996: 93: 7-9.
7. Kang S-S, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Am J Hum Genet 1991: 48: 536-545.
8. 12 are independent risk factors for neural tube defects. Q J Med 1993: 86: 703-708.
9. Kluijtmans LAJ, Blom HJ, Boers GHJ, Van Oost BA, Trijbels FJM, Van den Heuvel, LPWJ. Two novel missense mutations in the cystathionine β-synthase gene in homocystinuric patients. Hum Genet 1995: 96: 249-250.
10. Kraus JP. Molecular basis of phenotype expression in homocystinuria. J Inherit Metab Dis 1994: 17: 383-390.
11. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995: 345: 149-151.
12. MRC Vitamin Study Research Group. Prevention of neural tube detects: results of the Medical Research Council Vitamin Study. Lancet 1991: 338: 131-137.
13. Mudd SH, Levy HL, Skovby F. Disorders of transsulfration. In: Scriver CR, Beaudet AL, Sly WS, Valle, eds. The metabolic basis of inherited diseases. New York: McGraw Hill. 1989: 693-734.
14. Robinson K, Clarke R, Graham I. Hyperhomocystinemia and vascular disease. J Ir Coll Phys Surg 1991: 20: 25-29.
15. Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle, eds. The metabolic basis of inherited diseases. New York: McGraw Hill, 1989: 2049-2064.
16. Scott JM, Weir DG, Kirke PN. Folate and neural tube defects. In: Bailey LB, ed. Folate in health and disease. New York: Marcel Dekker Inc. 1995: 329-360.
17. Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G. The molecular basis of homocystinuria due to cyatathionine β-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet 1995: 56: 1324-1333.
18. Steegers-Theunissen RPM, Boers GHL, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CMG, Borm GF, Wouters MGAJ, Eskes TKAB. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 1994: 43: 1475-1480.
19. Tsai MY, Garg U, Key NS, Hanson NQ, Suh A, Schwichtenberg K. Molecular and biological approaches in the identification of heterozygotes for homocystinuria. Atherosclerosis 1996: 122: 69-77.
20. van der Put NM, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heyer M, Rozen R, Blom HJ. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995: 346: 1070-1071.
21. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995: 88: 763-766.